Color Study (High-Risk Breast Lesions) - Clinical Trial

What is the Purpose of this Study?

If you choose to join this study, you will:

- Give a saliva sample

- Have a genetic test using the Color Genomics 30 gene hereditary panel test

What is the Condition Being Studied?

Genetic Testing

Who Can Participate in the Study?

Women diagnosed with high-risk breast lesions including:

- Lobular carcinoma in situ (LCIS)

- Atypical ductal hyperplasia (ADH)

- Atypical lobular hyperplasia (ALH)

- Flat epithelial atypia (FEA)

- Columnar cell hyperplasia (CCH)

Age Group

What is Involved?

We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.

Study Details

Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00089223
NCT: NCT00000000
Phase N/A
Enrollment Status
Open for Enrollment